Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2017
Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing SarcomaHaibo Sun, De-Chen Lin, Qi Cao, et al.
Science Translational Medicine|May 27, 2021
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroupAurore Touzart, Anand Mayakonda, Charlotte Smith, et al.
Haematologica|January 12, 2023
TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancerCharlotte Smith, Ashish Goyal, Dieter Weichenhan, et al.
Cancers|March 6, 2020
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell LinesMartin Michaelis, Yvonne Voges, Florian Rothweiler, et al.
Cancer Research|March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cellsKai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastomaJessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Nucleic Acids Research|February 21, 2022
ALT-FISH quantifies alternative lengthening of telomeres activity by imaging of single-stranded repeatsLukas Frank, Anne Rademacher, Norbert Mücke, et al.
Pageof 18